Sponsored Links
02/22/2019 20 plazas to come up for Brand Khadi...Read More
02/22/2019 Ambani’s new content coup...Read More
02/22/2019 Bajaj Auto unveils its first car, the RE60...Read More
02/22/2019 Godrej Interio partners with Linet for healthcare biz...Read More
02/22/2019 Honeywell Turbo Tech to expand turbocharger portfolio in India...Read More
::News
Polls

FDI in Retail will affects farmer?

View Results

Loading ... Loading ...

Posts Tagged ‘Biocon’

Major corporate events (Milestone)
Year Events

1978 Biocon India incorporated as a joint venture between Biocon Biochemicals of Ireland and Kiran Mazumdar
1989 Unilever plc. acquires Biocon Biochemicals in Ireland and merges it with its subsidiary, Quest International
1996 Biocon enters the biopharmaceutical and statin segments
1998 Unilever signs an agreement with ICI to sell its specialty chemical division of which Quest International is a part. Unilever agrees to sell its shareholding in Biocon to the Indian promoters. Biocon becomes an independent entity
2000 Establishes Clinigene, India’s first clinical research organisation and a subsidiary of Biocon, to pursue clinical research and development
2001 Biocon becomes the first Indian company approved by US FDA for the manufacture of lovastatin, a cholesterol-lowering molecule
2004 Biocon lists on the BSE and NSE. Ends the first trading day with a market value of US$ .11bn the second Indian company to cross the US$1bn mark on the day of listing
2004 Biocon Limited announces the launch of INSUGENTM, the new generation bio-insulin, manufactured in Asia’s largest human insulin plant
2005 Biocon Limited signs a commercial agreement to supply of insulin API in Asia, Africa and the Middle East
2006 Biocon Limited launches India’s first cancer drug BIOMAb EGFR
Biocon

Biocon-Organisation Chart